Expertise in
24
conditions

Dr. Mackenzie D. Daly

Radiation Oncology
University Of Colorado Hospital
1665 Aurora Ct, 
Aurora, CO 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Expertise in
24
conditions
University Of Colorado Hospital
1665 Aurora Ct, 
Aurora, CO 

Overview

Mackenzie Daly is a Radiation Oncologist practicing medicine in Aurora, Colorado.

Dr. Daly is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Oligodendroglioma, Breast Cancer, and Glioblastoma.

She is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 8 clinical trials. Dr. Daly is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in MO

Hospital Affiliations

Uch-Memorial Health System
University Of Colorado Hospital Authority
Parkview Medical Center, Inc

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

University of Colorado Hospital
1665 Aurora Ct, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Enrollment Status: Recruiting
Publish Date: August 27, 2026
Intervention Type: Drug, Radiation
Study Drug: Pembrolizumab
Study Phase: Phase 2
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Enrollment Status: Recruiting
Publish Date: February 20, 2026
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: April 21, 2026
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Palbociclib, Cetuximab, Cisplatin
Study Phase: Phase 2
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drug: Cisplatin
Study Phase: Phase 2
Phase I/II Trial of Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV-unrelated Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Phase I/II Trial of Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV-unrelated Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Enrollment Status: Completed
Publish Date: February 03, 2025
Intervention Type: Drug, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 1
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT): A Pilot Study of Consolidated Simulation and Target Identification of Quad Shot Radiation Therapy Using an Adaptive Radiotherapy Workflow With a Novel Ring Gantry Radiotherapy Device
Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT): A Pilot Study of Consolidated Simulation and Target Identification of Quad Shot Radiation Therapy Using an Adaptive Radiotherapy Workflow With a Novel Ring Gantry Radiotherapy Device
Enrollment Status: Completed
Publish Date: December 08, 2023
Intervention Type: Radiation, Device
Study Phase: Not Applicable
Evaluation of TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers: a Pilot Study
Evaluation of TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers: a Pilot Study
Enrollment Status: Terminated
Publish Date: July 12, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

34 Total Publications

Palliative expeditiously adaptive quad shot radiotherapy for head and neck cancers (PEAQ-RT).
Palliative expeditiously adaptive quad shot radiotherapy for head and neck cancers (PEAQ-RT).
Journal: Clinical and translational radiation oncology
Published: March 28, 2025
Similar Doctors
Expertise in
37
conditions
Dr. Brian D. Kavanagh
Radiation Oncology
Expertise in
37
conditions
Dr. Brian D. Kavanagh
Radiation Oncology
Referral may be required

Office

1665 Aurora Ct Ste 1032, 
Aurora, CO 
 (0.4 miles away)
720-718-5160
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Kavanagh is a Radiation Oncologist practicing medicine in Aurora, Colorado. Dr. Kavanagh is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Astrocytoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Kavanagh is currently accepting new patients.

Expertise in
10
conditions
Dr. Christine M. Fisher
Radiation Oncology
Expertise in
10
conditions
Dr. Christine M. Fisher
Radiation Oncology
Referral may be required

University Of Colorado Hospital

12605 E 16th Ave, 
Aurora, CO 
 (0.2 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christine Fisher is a Radiation Oncologist practicing medicine in Aurora, Colorado. Dr. Fisher is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Breast Cancer, Endometrial Cancer, and Neuroendocrine Carcinoma of the Cervix. Dr. Fisher is currently accepting new patients.

Expertise in
9
conditions
Dr. Sarah A. Milgrom
Radiation Oncology
Expertise in
9
conditions
Dr. Sarah A. Milgrom
Radiation Oncology
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.1 miles away)
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Milgrom is a Radiation Oncologist practicing medicine in Aurora, Colorado. She has been practicing medicine for over 17 years. Dr. Milgrom is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Cutaneous T-Cell Lymphoma (CTCL), and Mediastinal Tumor. Dr. Milgrom is currently accepting new patients.

Frequently Asked Questions about Dr. Mackenzie D. Daly

Is Dr. Mackenzie D. Daly a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mackenzie D. Daly is classified as an Advanced expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mackenzie D. Daly specialize in?

While Dr. Mackenzie D. Daly is a Radiation Oncology, they have specific expertise in Astrocytoma, Oligodendroglioma, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mackenzie D. Daly participate in research or clinical trials?

Yes. Dr. Mackenzie D. Daly has published 34 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Mackenzie D. Daly's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mackenzie D. Daly accept my insurance?

Dr. Mackenzie D. Daly accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Daly's expertise for a condition
ConditionClose
      View All 24 Advanced Conditions
      View All 42 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile